Global Next-Generation Biologics Market 2016-2020


#892950

124pages

Technavio

$ 2500

In Stock

About Next-generation Biologics

According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition or disease of human beings. Biologic therapeutics include virus, toxins, allergenic products, therapeutic serums, antitoxin, blood components or derivatives, vaccines, blood, proteins (except any chemically synthesized polypeptide), or analogous products, or arsphenamine or derivative of arsphenamine intended for the treatment, prevention, or cure of a disease or condition. The differences between the small molecules and biologics includes the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics usually have a higher molecular weight and a complex molecular structure. They are usually derived from living organisms, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures and light.

Technavios analysts forecast the global next-generation biologics market to grow at a CAGR of 14.42% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global next-generation biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of next-generation biologics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Next-generation Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
F. Hofmann-La Roche
Novo Nordisk
Sanofi
Takeda Pharmaceuticals

Other prominent vendors
Aastrom Biosciences
AbbVie
AbGenomics
Acologix
ADC Therapeutics
Adocia
Agensys
AlloCure
AlloSource
ALMAC Group
Alphatec Spine
Ambrx
Amorcyte
Argos Therapeutics
Astellas Pharma
AstraZeneca
Athersys
Avita Medical
Baxter
Bayer HealthCare
Bellicum Pharmaceuticals
BioCardia
Biocon
Biodel
BIOGENOMICS
BioLife Solutions
BioRestorative Therapies
BioTissue Technologies
Bluebird Bio
Boehringer Ingelheim
BrainStorm Cell Therapeutics
Calimmune
Capricor
CARBOGEN AMCIS
Cell Medica
Celldex Therapeutics
Celyad (Cardio3 BioSciences)
Cesca
CryoLife
CSL Behring
Cynata Therapeutics
Daiichi Sankyo
Dance Biopharm
Dendreon
Diasome Pharmaceuticals
DiscGenics
Endo Pharmaceuticals
Esperance Pharmaceuticals
Exsulin
Fate Therapeutics
Fibrocell Science
Formation Biologics
Forticell Bioscience
Fortress Biotech
Gamida Cell
GENEREX
Genmab
Geron
GlaxoSmithKline
Harvard Apparatus Regenerative Technology
Healthpoint
Histogen
Histogenics
Humacyte
Immunocellular Therapeutics
Immunogen
Integra LifeSciences
InVivo Therapeutics
ISTO Technologies
Juno Therapeutics
Juventas Therapeutics
Kairos Therapeutics
Kensey Nash
Kiadis Pharma
Kinetic Concept
Living Cell Technologies
MacroGenics
MannKind
MaxCyte
MedImmune
Medtronic
Mersana Therapeutics
Mesoblast
MiMedx
Nanofiber Solutions
Nanotope
Neuralstem
NewLink Genetics
NGM Biopharmaceuticals
Northwest Biotherapeutics
Novartis
NovaRx
Ocata Therapeutics
Opexa Therapeutics
Oramed Pharmaceuticals
Organovo
Orteq
Orthofix
Osiris Therapeutics
Osteotech
OXFORD BioTherapeutics
Pfizer
PhaseBio Pharmaceuticals
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
ReproCELL
RhinoCyte
RTI Surgical
SanBio
Sangamo
Shire Regenerative Medicine
STEMCELL Technologies
Stemcentrx
Stratatech
Synthon Biopharmaceuticals
TEI Biosciences
Tengion
Thermalin Diabetes
TiGenix
Tissue Genesis
TissueGene
Tolerion
VentriNova
Vericel
VeroScience
ViaCyte
VistaGen Therapeutics
vTv Therapeutics
Wockhardt
XOMA
Zimmer Biomet
Zymeworks

Market driver
Advanced technological innovations
For a full, detailed list, view our report

Market challenge
Complexities in manufacturing of biologics
For a full, detailed list, view our report

Market trend
Development of gene and cell therapy-based products
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.